Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
Intestinal Neutral Ceramidase Deficiency Triggers Regulatory T Cell Response via Gd3 to Protect the Host from Intestinal Inflammation.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xu Zhishan, Lei Chao, Sriwastva Mukesh K, Wang Ting, Tuohongerbieke Amanguli, Song Xiaotong, Noud Collin, Derkson Shannon, Tan Yi, Dryden Gerald, McClain Craig J, Deng Zhongbin
Аннотация
Sphingolipids play a crucial role in gut inflammation. Neutral ceramidase (NcDase) serves as a pivotal regulator of ceramide, the central intermediate in sphingolipid metabolism. The contribution of intestinal epithelial cells (IEC) NcDase to colitis is not well understood. Here, a protective mechanism by which IEC NcDase deficiency (Asah2ΔIEC) and its-related gangliosides prevent dextran sulfate sodium (DSS)-induced colitis in mice is described. Asah2ΔIEC mice display reduced susceptibility to DSS-induced colitis and increase regulatory T (Treg) cells compared to Asah2fl/fl littermates. Deletion of IEC NcDase induces the upregulation of sialyltransferase ST8SIA1 and promotes the sialic-acid-containing ganglioside GD3 production. Siglec-E is a sialic-acid-binding lectin expresses predominantly on myeloid cells. Mechanistically, it is identified that GD3 is a functional ligand for Siglec-E on macrophages and found that GD3/Siglec-E interaction induced a rapid metabolic rewiring of macrophages that involved the production of IL-33, which contributes to the generation of ST2+Foxp3+ Treg cells. Finally, deletion of ST8SIA1 or administration of dietary GD3 induces or reduces mucosal inflammation, respectively. This work defines a critical role for ganglioside GD3 in the induction of colonic Treg cells and identifies an activating pathway that follows engagement of Siglec-E.